• a decrease in Amortization of intangible assets of $70 million primarily attributable to fully amortized intangible assets no longer being amortized in 2023; • a favorable change in Other (income) expense, net of $62 million primarily attributable to: (i) insurance recoveries and (ii) adjustments to reflect changes in estimates of the liability for Acquisition-related contingent consideration. RESULTS OF OPERATIONS Revenues 57 | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------- ...

Bausch Health Companies Inc. (NYSE:BHC) Q1 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Mark Maico - Investor Relations Conference Call Participants Glen Santangelo - Jefferies Douglas Miehm - RBC Capital Markets David Amsellem - Piper Sandler Qi Yang - Bank of America Operator Greetings. Welcome to Bausch Health First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 98-0448205 (State or ot ...

| --- | --- | --- | --- | |-------|-------------------|-----------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4Q22 and FY22 | Earnings Presentation | | | | February 23, 2023 | | | Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements relating to Bausch Health Companies Inc.'s ("Bausch Hea ...

Bausch Health Companies Inc. (NYSE:BHC) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Georgi Yordanov - Cowen and Company Douglas Miehm - RBC Capital Markets Glen Santangelo - Jefferies David Amsellem - Piper Sandler Jason Gerberry - Bank of America Gary Nachman - BMO Umer Raffat - Evercore ISI Operator Good morning, and welcome to Bausch Health's Fourth Quarter 202 ...

Changes in inventory levels or fluctuations in buying patterns by our large distributor and retail customers may adversely af ect our sales and earnings and add to sales variability from quarter to quarter. We have a significant number of unique products, and we anticipate that number will continue to grow over time. As a result, the demand forecasting precision required for us to avoid production capacity issues will also increase, which could increase the risk of product unavailability and lost sales. Add ...

Third Quarter 2022 Earnings Call November 3, 2022 Forward-looking statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements relating to Bausch Health Companies Inc.'s ("Bausch Health" or the "Company") future prospects and performance, financial guidance, proposed plan to fully separate its eye health business, including the timing thereof, anticipa ...

Bausch Health Companies Inc. (NYSE:BHC) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Christina Cheng - Senior Vice President, Investor Relations and Communications Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Georgi Yordanov - Cowen Umer Raffat - Evercore Greg Fraser - Truist Securities Douglas Miehm - RBC Capital Markets Rishi Parekh - JPMorgan Operator Good morning, ladies ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State ...

Bausch Health Companies Inc. (NYSE:BHC) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Christina Cheng - Senior Vice President, Investor Relations Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Gary Nachman - BMO Greg Fraser - Truist Securities Umer Raffat - Evercore Sahil Dhingra - RBC Operator Good morning and welcome to the Bausch Health Second Quarter 2022 ...